Next-Generation Imaging

Latest News

Multi-dose phase of 64Cu/67Cu-SAR-bisPSMA study begins in mCRPC
Multi-dose phase of 64Cu/67Cu-SAR-bisPSMA study begins in mCRPC

March 18th 2024

Among all patients treated in the study to date, 60% demonstrated a PSA reduction of greater than 35%, and 27% demonstrated a PSA reduction of greater than 80%.

Commercial supply of piflufolastat (18F) begins in Italy
Commercial supply of piflufolastat (18F) begins in Italy

March 8th 2024

Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Dr. Reiter discusses accuracy of PSMA-PET scans

March 5th 2024

3d rendered medically accurate illustration of prostate cancer | Image Credit: @ SciePro - @ SciePro - stock.adobe.com
PSMA-PET leads imaging breakthroughs in prostate cancer paradigm

February 23rd 2024

Study launches of BNT316/ONC-392 plus radioligand therapy in mCRPC
Study launches of BNT316/ONC-392 plus radioligand therapy in mCRPC

February 22nd 2024

Video Series
Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.